This grant opportunity (RFA-CA-26-002) from the NIH supports the advanced development and validation of emerging technologies for basic and clinical cancer research. Clinical trials are not allowed under this R33 grant.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Research and Development Services for Emerging Cancer Technologies
1
lot
$500,000.00
$500,000.00
Professional Services
Validation Services for Emerging Cancer Technologies
1
lot
$500,000.00
$500,000.00
Professional Services
Estimated Bid Value
$1,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.